Barbara Serafini Selected Research

TWEAK Receptor

12/2008

Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Serafini Research Topics

Disease

18	Multiple Sclerosis 10/2022 - 04/2004
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2008 - 09/2002
3	Epstein-Barr Virus Infections 01/2018 - 07/2010
2	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 12/2019
2	Megalencephalic leukoencephalopathy with subcortical cysts 12/2019 - 03/2010
2	Inflammation (Inflammations) 01/2017 - 07/2008
2	Rheumatoid Arthritis 09/2013 - 02/2011
2	Neuroinflammatory Diseases 07/2008 - 01/2003
1	Celiac Disease (Celiac Sprue) 10/2022
1	Gliosis 12/2019
1	Immune Reconstitution Inflammatory Syndrome 01/2018
1	Osteoarthritis 09/2013
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2013
1	Tertiary Lymphoid Structures 07/2008
1	Disease Progression 10/2006
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 08/2005
1	Infections 08/2005
1	Arthritis (Polyarthritis) 08/2004

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 10/2022 - 02/2006
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2006
4	ChemokinesIBA 07/2008 - 01/2003
3	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2013
3	CytokinesIBA 01/2020 - 12/2008
2	Membrane Proteins (Integral Membrane Proteins)IBA 12/2019 - 03/2010
2	Natalizumab (Tysabri)FDA Link 01/2018 - 01/2017
2	AntibodiesIBA 09/2013 - 07/2010
2	InterferonsIBA 02/2011 - 05/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010 - 12/2008
2	Oligoclonal BandsIBA 09/2008 - 04/2004
1	Glutens (Glutelin)IBA 10/2022
1	Antiviral Agents (Antivirals)IBA 10/2022
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020
1	LipidsIBA 01/2018
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 03/2015
1	AutoantigensIBA 09/2013
1	DNA (Deoxyribonucleic Acid)IBA 09/2013
1	Peptides (Polypeptides)IBA 09/2013
1	NK Cell Lectin-Like Receptor Subfamily BIBA 02/2011
1	B-Cell Activating FactorIBA 07/2010
1	TWEAK ReceptorIBA 12/2008
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2008
1	Interferon-betaIBA 05/2008
1	Immunoglobulins (Immunoglobulin)IBA 10/2006
1	Lymphotoxin-alpha (Lymphotoxin)IBA 10/2006
1	Lymphotoxin beta ReceptorIBA 10/2006
1	PrionsIBA 08/2005
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 02/2003
1	Chemokine CCL22IBA 09/2002

Therapy/Procedure

1	Lasers (Laser) 01/2018
1	Therapeutics 05/2008